ONC logo

ONC BeOne Medicines AG

NASDAQ · Biotechnology · Healthcare

$390.94
-8.76 (-2.19%)

BeOne Medicines AG, an oncology-focused enterprise headquartered in Basel, Switzerland, was established in 2010. This company is actively involved in the exploration and advancement of a diverse range of therapeutic solutions for cancer patients across key global regions, including the United States, China, Europe, and other international markets. Its current commercial portfolio features several …

Market Cap: $41.78Bbeonemedicines.com

Price

No data yet.

Social Signal Score

44
5d
—
30d
40
6 mentions
—
60d
44
10 mentions
—
90d
47
13 mentions
—
news: 13

Analyst Ratings

15 analysts
Buyconsensus
Strong Buy 0Buy 15Hold 0Sell 0Strong Sell 0
Avg price target$426.5+9.1%
Low $370Median $422.5High $470
Current Consensus

Revenue

$1.89B
$0.00$629.94M$1.26B$1.89B
Dec 2016Sep 2026

Analyst Estimates

FY2025
$3.01
$2.65–$3.46
10 analysts
FY2026
$9.00+199% YoY
$5.56–$11.68
11 analysts
FY2027
$10.56+17% YoY
$9.51–$11.65
12 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
John V. Oyler
Sector
Healthcare
Industry
Biotechnology
Employees
12,000
Beta
0.52
Country
CH
Piotroski score
6 / 9 (Middling)
Altman Z-score
6.92
beonemedicines.com